Acinetobacter baumannii genome sequence determined

Italy - The genome sequence of Acinetobacter baumannii has been determined by scientists at the Istituto di Tecnologie Biomediche, the Dipartimento di Malattie Infettive at the Istituto Superiore della Sanità and the Dipartimento di Biologia at Roma Tre University. In Italy alone this antibiotic resistant pathogen causes 4,500 to 7,000 deaths annually.

Genome sequencing is the foundation for rapid diagnosis and targeted therapy approaches, said project manager Gianluca de Bellis. ‘Sequencing was made possible by a further improved technique which can generate more than 100 million DNA bases within a few hours. This translates into a significant time and cost advantage over the previous methods.’ Using this sequencing method the Italian scientists hope to identify new substances for the development of new antibiotics. The phenomenon of antibiotic resistance will be examined from a basic and applied research angle.
This genetic sequence is available free, via www.itb.cnr.it/genome-project.

01.07.2008

News • Research on Antrodia cinnamomea

Promising fungal compound to fight cancer and inflammation

Studies have found that natural polysaccharides from a medical fungus endemic to Taiwan can not only effectively inhibit inflammation, but also fight the proliferation of lung cancer cells.

News • Patient involvement enables research

Tumor vesicles as a promising biomarker for early cancer detection

Tumor vesicles may serve as early indicators of cancer and help monitor the effectiveness of treatments. Now, researchers discovered a new way to detect these vesicles.

News • From erythroblasts to erythrocytes

One step closer to artificial blood production

A breakthrough in the understanding of how mammals create red blood cells could lead to opportunities for articifical blood to be created at scale for the first time.